Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa

Ítems similars

• Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
  per: Shean, Karen, et al.
  Publicat: (2013)
• What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
  per: Pooran, Anil, et al.
  Publicat: (2013)
• Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.(®)TB and QFT-GIT)
  per: van Zyl-Smit, Richard N., et al.
  Publicat: (2016)
• The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates
  per: Tomasicchio, Michele, et al.
  Publicat: (2016)
• Lichenoid drug reaction to antituberculosis drugs treated through with topical steroids and phototherapy
  per: Lehloenya, Rannakoe J., et al.
  Publicat: (2012)